These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26814914)

  • 21. Thalidomide for necrobiotic xanthogranuloma.
    Ali FR; Lear JT
    Clin Exp Dermatol; 2022 Apr; 47(4):769-770. PubMed ID: 34856016
    [No Abstract]   [Full Text] [Related]  

  • 22. Necrobiotic Xanthogranuloma: A Cutaneous Manifestation of Monoclonal Gammopathy.
    Pérez-López I; Herrera-García JD; Martínez-López A; García-Durá E
    Actas Dermosifiliogr (Engl Ed); 2018 Nov; 109(9):827. PubMed ID: 29615198
    [No Abstract]   [Full Text] [Related]  

  • 23. [Disseminated necrobiotic xanthogranuloma].
    Klingner M; Hansel G; Schönlebe J; Wollina U
    Hautarzt; 2016 Nov; 67(11):902-906. PubMed ID: 27380383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
    Seastrom S; Bookout A; Hogan DJ
    Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Necrobiotic xanthogranuloma. Differential diagnosis, treatment and systemic involvement. Case report].
    Sanz-Marco E; España E; López-Prats MJ; Chirivella-Casanova M; Aviño J; Díaz-Llopis M
    Arch Soc Esp Oftalmol; 2014 May; 89(5):186-9. PubMed ID: 24269389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diffuse plane normolipemic xanthomatosis and necrobiotic xanthogranuloma associated with monoclonal gammopathy--determining the disease stage with PET-CT and treatment experience. Two case studies and literature review].
    Adam Z; Zahradová L; Krejcí M; Pour L; Koukalová R; Rehák Z; Feit J; Kren L; Mechl M; Vasků V; Sirotková A; Hájek R; Mayer J
    Vnitr Lek; 2010 Nov; 56(11):1158-68. PubMed ID: 21250495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necrobiotic xanthogranuloma.
    Jaén-Águila F; Vargas-Hitos JA; Jiménez-Alonso J
    QJM; 2014 Oct; 107(10):859. PubMed ID: 24659748
    [No Abstract]   [Full Text] [Related]  

  • 28. Necrobiotic xanthogranuloma associated with monoclonal gammopathy of unknown significance.
    Melguizo Moya I; Navarro Puerto MA; Grilo Reina A
    Med Clin (Barc); 2017 Dec; 149(11):509-510. PubMed ID: 28736067
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment of scleromyxedema with melphalan and dexamethasone followed by thalidomide maintenance therapy.
    Cao XX; Wang T; Liu YH; Zhou DB; Li J
    Leuk Lymphoma; 2016 Dec; 57(12):2934-2936. PubMed ID: 27118492
    [No Abstract]   [Full Text] [Related]  

  • 30. Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
    Hopfinger G; Nösslinger T; Lang A; Linkesch W; Melchardt T; Weiss L; Egle A; Greil R
    Ann Hematol; 2014 Mar; 93(3):459-62. PubMed ID: 24441915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized necrobiotic xanthogranuloma successfully treated with lenalidomide.
    Silapunt S; Chon SY
    J Drugs Dermatol; 2010 Mar; 9(3):273-6. PubMed ID: 20232591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Necrobiotic xanthogranuloma with giant cell hepatitis, successfully treated with intravenous immunoglobulins.
    Pedrosa AF; Ferreira O; Calistru A; Mota A; Baudrier T; Sarmento JA; Bettencourt H; Azevedo F
    Dermatol Ther; 2015; 28(2):68-70. PubMed ID: 25650024
    [No Abstract]   [Full Text] [Related]  

  • 33. Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration.
    Ghiasi N; Alavi A; Coutts PM; Ghazarian D; Sibbald RG
    Int J Low Extrem Wounds; 2012 Dec; 11(4):293-5. PubMed ID: 23222162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Necrobiotic Xanthogranuloma as the Presenting Manifestation of Smouldering Myeloma.
    Makkar N; Niyas VKM; Swain S; Sethi P; Nischal N; Agarwal S; Ramam M; Wig N
    J Assoc Physicians India; 2019 Mar; 67(3):87-88. PubMed ID: 31304718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide-dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement.
    Meyer S; Szeimies RM; Landthaler M; Hohenleutner S
    Br J Dermatol; 2005 Aug; 153(2):443-5. PubMed ID: 16086766
    [No Abstract]   [Full Text] [Related]  

  • 36. Vulvar necrobiotic xanthogranuloma.
    DeLuca IJ; Grossman ME
    J Am Acad Dermatol; 2014 Dec; 71(6):e247-8. PubMed ID: 25454046
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of necrobiotic xanthogranuloma with total glucosides of paeony.
    Li S; Chen AJ; Fang S; Li H
    Dermatol Ther; 2014; 27(5):304-6. PubMed ID: 24774012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slowly growing yellow nodules: challenge. Necrobiotic xanthogranuloma.
    Gergen N; Biebl K; Berg BC; Suwattee P
    Am J Dermatopathol; 2011 Feb; 33(1):92-3, 103-4. PubMed ID: 20644464
    [No Abstract]   [Full Text] [Related]  

  • 39. [Necrobiotic xanthogranuloma revealing an IgA gammapathy].
    Bayou F; Belhadjali H; Youssef M; Njim L; Zakhama A; Jameleddine ZJ
    Presse Med; 2012 Feb; 41(2):204-6. PubMed ID: 21885233
    [No Abstract]   [Full Text] [Related]  

  • 40. Slow increase of bilirubin concentration during administration of lenalidomide, bortezomib and dexamethasone for multiple myeloma (unmasking previously undiagnosed Gilbert syndrome) and disappearance of necrobiotic xanthogranuloma after complete remission of multiple myeloma.
    Adam Z; Řehák Z; Adamová Z; Pour L; Dvořáková K; Packová B; Koukalová R; Krejčí M; Krejčí M; Štork M; Sandecká V; Boichuk I; Král Z
    Klin Onkol; 2022; 35(4):315-322. PubMed ID: 35989089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.